OpenFilings

ORAMED PHARMACEUTICALS INC.

Form10-K

Report Period2023-12-31

Date Filed2024-03-06

Time Filed17:00:35

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

ANNUAL REPORT
AMENDMENT, DATED APRIL 27, 2023, TO CONSULTING AGREEMENT BY AND BETWEEN ORAMED P
AMENDMENT, DATED JANUARY 8, 2024, TO CONSULTING AGREEMENT BY AND BETWEEN ORAMED
AMENDMENT, DATED APRIL 27, 2023, TO EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED L
AMENDMENT, DATED JANUARY 8, 2024, TO EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED
AMENDMENT, DATED APRIL 27, 2023, TO CONSULTING AGREEMENTS BY AND BETWEEN ORAMED
AMENDMENT, DATED JANUARY 8, 2024, TO CONSULTING AGREEMENTS BY AND BETWEEN ORAMED
THIRD AMENDMENT, DATED APRIL 27, 2023, TO EMPLOYMENT AGREEMENT, BY AND BETWEEN O
FOURTH AMENDMENT, DATED JANUARY 8, 2024, TO EMPLOYMENT AGREEMENT, BY AND BETWEEN
REPRESENTATIVE FORM OF INDEMNIFICATION AGREEMENTS BETWEEN ORAMED PHARMACEUTICALS
CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CERTIFICATION
CERTIFICATION
CERTIFICATION
CERTIFICATION
ORAMED PHARMACEUTICALS INC. CLAWBACK POLICY, ADOPTED NOVEMBER 9, 2023
Filing on SEC Edgar